Ono Pharmaceutical CoMEX:4528N 88 Quick Ratio is 2.51 as of Mar. 2026, which is 1% below its 10-year median of 2.54. GuruFocus rates MEX:4528N with a GF Score™ of 88/100 and a GF Value™ of MXN324.16. The stock has 2 warning signs investors should review. Among 994 Drug Manufacturers companies, Ono Pharmaceutical Co ranks better than 71.23% on this metric.
Ono Pharmaceutical Co has a quick ratio of 2.51. It generally indicates good short-term financial strength.
The historical rank and industry rank for Ono Pharmaceutical Co's Quick Ratio or its related term are showing as below:
MEX:4528N'
s Quick Ratio Range Over the Past 10 Years
Min: 1.95 Med: 2.54 Max: 3.63
Current: 2.51
During the past 13 years, Ono Pharmaceutical Co's highest Quick Ratio was 3.63. The lowest was 1.95. And the median was 2.54.
MEX:4528N's Quick Ratio is ranked better than 71.23% of 994
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs MEX:4528N: 2.51
Ono Pharmaceutical Co (MEX:4528N) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Ono Pharmaceutical Co Quick Ratio Related Terms
Ono Pharmaceutical Co Quick Ratio Historical Data
* Premium members only.
The historical data trend for Ono Pharmaceutical Co's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:4528N vs LLY, JNJ, ABBV: Quick Ratio Comparison
For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ono Pharmaceutical Co Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Ono Pharmaceutical Co's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Ono Pharmaceutical Co's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ono Pharmaceutical Co (MEX:4528N) has a Quick Ratio of 2.51 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Ono Pharmaceutical Co and its competitors. This is near median its historical median of 2.54. Over the past decade, Ono Pharmaceutical Co's Quick Ratio has ranged from 1.95 to 3.63. According to the industry distribution chart, Ono Pharmaceutical Co ranks #286 out of 994 companies in the Drug Manufacturers industry, placing it in the top 28.8%.
Is Ono Pharmaceutical Co's Quick Ratio too high?
Ono Pharmaceutical Co's current Quick Ratio of 2.51 is near median its 10-year median of 2.54. Over the past 10 years, this metric has ranged from a low of 1.95 to a high of 3.63. The Drug Manufacturers industry median Quick Ratio is 1.45. Ono Pharmaceutical Co's value of 2.51 is 73.1% above this industry median. Based on the distribution chart, Ono Pharmaceutical Co ranks #286 out of 994 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ono Pharmaceutical Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Quick Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Ono Pharmaceutical Co ranks #286 out of 994 companies for Quick Ratio. This puts Ono Pharmaceutical Co in the upper half of its industry. The industry median Quick Ratio is 1.45. Ono Pharmaceutical Co's value of 2.51 is 73.1% above this benchmark. Historically, Ono Pharmaceutical Co's own Quick Ratio has ranged from 1.95 to 3.63 over the past decade. While the company's 10-year median is 2.54 vs. the industry median of 1.45, Ono Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ono Pharmaceutical Co's current Quick Ratio of 2.51 is 73.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Ono Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ono Pharmaceutical Co's current Quick Ratio is 2.51, which is near median its own 10-year median of 2.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Ono Pharmaceutical Co (MEX:4528N) has a current Quick Ratio of 2.51. The stock's GF Value™ is MXN324.16, compared to a current price of MXN341.69 — trading 5.4% above its estimated fair value. The current Quick Ratio is 2.51, which is near median its 10-year median of 2.54 and 73.1% above the Drug Manufacturers industry median of 1.45. Ono Pharmaceutical Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Ono Pharmaceutical Co (MEX:4528N), the current Quick Ratio is 2.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ono Pharmaceutical Co (MEX:4528N) Overvalued in 2026?
Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued.
The current stock price of MXN341.69 is trading 5.4% above its estimated GF Value™ of MXN324.16.
Key valuation signals for MEX:4528N:
Quick Ratio: 2.51 (near median its 10-year median of 2.54)
GF Value™: MXN324.16 vs. price of MXN341.69 (5.4% above fair value)
Industry Position: 73.1% above the Drug Manufacturers median (#286 of 994)
No single metric tells the full story. See the MEX:4528N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
88GF Score
Get the complete analysis for MEX:4528N
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4528N has been successfully added to your 
